Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension.

Richard J NowakAri BreinerVera BrilJeffrey A AllenShaida KhanTodd LevineDaniel H JacobsGregory SahagianZaeem A SiddiqiJing XuWilliam L MaciasMichael Benatarnull null

Published in: Annals of clinical and translational neurology (2023)

The safety profile, pharmacodynamics, and preliminary clinical benefits observed in this study support further investigation of subcutaneous batoclimab injections as a potential patient-administered therapy for seropositive generalized myasthenia gravis.

Keyphrases

myasthenia gravis
clinical trial
study protocol
case report
phase iii
platelet rich plasma
open label